Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00546767 · ClinicalTrials.gov registry record · NA
Home-Based Assessment for Alzheimer Disease Prevention
A NA study, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
- Completed
- Registry status
- NA
- Development phase
- 640
- Enrollment target
NCT00546767: Completed NA study, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
NCT00546767 is a NA study that has completed, run by Alzheimer's Disease Cooperative Study (ADCS). The registered enrollment target is 640 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00546767, a NA study, has completed, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
- COMPLETED
- Registry status
- NA
- Development phase
- 640 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate three methods of performing home-based assessments in Alzheimer's Disease (AD) prevention trials. The initial in-person assessment will be done in the clinic or at home.
Interventions
- BEHAVIORAL Interactive Voice Response (IVR)
- BEHAVIORAL Mail and Live Phone
- BEHAVIORAL Home-based Computer Kiosk
- BEHAVIORAL Traditional Evaluation Instruments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00546767 record still lists
NCT00546767 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 4 interventions - of which Interactive Voice Response (IVR) is the first listed.
NCT00546767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00546767 about?
NCT00546767 is a clinical study titled "Home-Based Assessment for Alzheimer Disease Prevention". The purpose of this study is to evaluate three methods of performing home-based assessments in Alzheimer's Disease (AD) prevention trials. The initial in-person assessment will be done in the clinic or at home.
What is the current status of trial NCT00546767?
This trial is currently completed. It is a NA study. The enrollment target is 640 participants. The study started on 2007-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00546767?
The interventions under investigation include: Interactive Voice Response (IVR) (BEHAVIORAL), Mail and Live Phone (BEHAVIORAL), Home-based Computer Kiosk (BEHAVIORAL), Traditional Evaluation Instruments (BEHAVIORAL).
Who is sponsoring clinical trial NCT00546767?
This trial is sponsored by Alzheimer's Disease Cooperative Study (ADCS), which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00546767's enrollment target sits among peer trials
640 156th of 2000 higher than 1,844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia